44 cloud-computing-phd-business Fellowship research jobs at UNIVERSITY OF SOUTHAMPTON
Sort by
Refine Your Search
-
funders. It is essential that you have a PhD in computer science, or equivalent professional qualifications and experience; ideally your PhD or equivalent professional qualifications and experience will be
-
, faster, longer? Future of Healthful Work – a large scale interdisciplinary program we’re leading asks the question “what if work were healthful from the outset, rather than being something from which we
-
delivery of our innovative NxtGen Researcher Programme and help establish the NxtGen Researcher Academy. This multi-disciplinary position focuses on engaging young people in health research, combining
-
in computer science, or equivalent professional qualifications and experience; ideally your PhD or equivalent professional qualifications and experience will be in distributed database systems
-
associated with the running of the project and the requirements of our funders. It is essential that you have a PhD in computer science, or equivalent professional qualifications and experience; ideally your
-
, along with an aptitude for developing new experimental techniques that relate to this exciting research program. To be successful with your application, you will need to demonstrate: An awarded PhD in
-
The University of Southampton are seeking to appoint a fixed term research fellow to facilitate and deliver a programme of research on a Faraday Institution funded project: SL2FBat - Sustainable Low
-
multiple long-term conditions navigate their social care needs. The position is full-time fixed-term until 01/04/2026. About you You will hold a PhD or equivalent professional qualification and experience
-
an impact, apply to join our team! Applications for Research Fellow positions will be considered from candidates who are working towards or nearing completion of a relevant PhD qualification. The title
-
the laboratory of Professors Ward and Ober. Their interdisciplinary research program is dedicated to the development of novel antibody-based therapeutics that has led to several therapeutics that are currently in